StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/3011% above fair value
$920.69−2.65 (-0.29%)

Close on Nov 20, 2026Market cap $95.24BP/E 20.3Yield –

Regeneron Pharmaceuticals Community & STEM Impact by Year

Community & STEM Impact — Students Supported with a STEM Experience [annual] (students)

Regeneron Pharmaceuticals Community & STEM Impact: 885,033 in FY2024, up 31.8% from a year earlier. No newer figure appears in the documents we track.

Latest, FY2024
885,033
Period ended Dec 31, 2024
Change on a year earlier
+31.8%
671,680 in FY2023
History
5 years
Since FY2020
Sources
1
2024 Regeneron Responsibility Report

Where the FY2024 figure comes from

“Students Supported With a STEM Experience 885,033 671,680 600,944 558,026 533,064”

Source: 2024 Regeneron Responsibility Report ↗

Reported in Regeneron Responsibility Reports (ESG Performance Data Table).

annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCommunity & STEM Impact — Students Supported with a STEM Experience [annual] (students)Year on yearSource
FY2024Dec 31, 2024885,033+31.8%2024 Regeneron Responsibility Report ↗
FY2023Dec 31, 2023671,680+11.8%2024 Regeneron Responsibility Report ↗
FY2022Dec 31, 2022600,944+7.7%2024 Regeneron Responsibility Report ↗
FY2021Dec 31, 2021558,026+4.7%2024 Regeneron Responsibility Report ↗
FY2020Dec 31, 2020533,064–2024 Regeneron Responsibility Report ↗

Breakdown

What makes up community & STEM Impact

Cite this data

StockData. (2026). Regeneron Pharmaceuticals Community & STEM Impact, annual FY2020–FY2024 [Data set]. Compiled from Regeneron Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/regn/kpis/esg-stem-students

See every metric in the Regeneron Pharmaceuticals KPI table. Data updated Nov 4, 2026.

See a number that looks wrong?